https://socictopen.socict.org/files/original/6adb7644f5e459de2bc387f29b5ad70f.pdf dd6d37a76d4d4d0b7751504d1b6c5138 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource An investor's perspective on infectious diseases and their influence on market behavior Creator An entity primarily responsible for making the resource Yi-Hsien Wang, Fu-Ju Yang, Li-Je Chen Description An account of the resource Recently, increasing number of infectious diseases has swept the world. The outbreak of a contagious disease not only affects the health and lives of people but also causes economic growth to stagnate. Business in the biotechnology industry is closely related to infectious diseases but what exactly is the information value of the outbreak of infectious disease on biotechnology? This study investigates how such outbreaks can affect the performance of biotechnology stocks. In the past 10 years, major statutory infectious diseases in Taiwan have included ENTEROVIRUS 71, DENGUE FEVER, SARS and H1N1. The empirical results indicate that there is a significant abnormal return on company shares in Taiwan's biotechnology industry because of statutory infectious epidemics. The relationship between the financial ratios of biotechnology companies and abnormal returns was analyzed as part of this research. The results show that the influence on R&D ratios, current ratios and assets are significant. Empirical findings reveal that the investors rationally measure operating conditions of the biotechnology companies during outbreaks of major infectious disease and adjust portfolio allocation accordingly. Date A point or period of time associated with an event in the lifecycle of the resource 2013 Subject The topic of the resource biotechnology industry, infectious diseases, investor's perspective, Abnormal Returns, stock performance, risk factor Identifier An unambiguous reference to the resource within a given context DOI: 10.3846/16111699.2012.711360 Source A related resource from which the described resource is derived Journal of Business Economics and Management Publisher An entity responsible for making the resource available Vilnius Gedinimas Technical University Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Business Language A language of the resource EN